Miriam Mateos-Haro, Monica Novoa-Candia, Guillermo Sánchez Vanegas, Andrea Correa-Pérez, Andrea Gaetano Gil, Silvia Fernández-García, Daniel Ortega-Quijano, Mayra Gizeth Urueña Rodriguez, David Saceda-Corralo, Tayeb Bennouna-Dalero, Lucia Giraldo, Jaqueline Tomlinson, Sergio Vaño-Galván, Javier Zamora
BACKGROUND: Alopecia areata is an autoimmune disease leading to nonscarring hair loss on the scalp or body. There are different treatments including immunosuppressants, hair growth stimulants, and contact immunotherapy. OBJECTIVES: To assess the benefits and harms of the treatments for alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) in children and adults. SEARCH METHODS: The Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase, ClinicalTrials...
October 23, 2023: Cochrane Database of Systematic Reviews